<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press Releases</title>
	<atom:link href="https://www.worldpharmatoday.com/press-releases/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Tue, 06 Oct 2026 13:04:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Press Releases</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>UCB Reports New EADV Data on Bimekizumab Treatment in HS</title>
		<link>https://www.worldpharmatoday.com/press-releases/ucb-reports-new-eadv-data-on-bimekizumab-treatment-in-hs/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 13:04:07 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ucb-reports-new-eadv-data-on-bimekizumab-treatment-in-hs/</guid>

					<description><![CDATA[<p>UCB has announced new three-year data for bimekizumab in moderate to severe hidradenitis suppurativa (HS), with findings presented at the European Academy of Dermatology and Venereology (EADV) 2026 Congress in Vienna, Austria. The data indicate higher rates of complete resolution of inflammatory lesions among patients receiving bimekizumab treatment earlier, while biologic-naïve patients showed improved outcomes [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/ucb-reports-new-eadv-data-on-bimekizumab-treatment-in-hs/">UCB Reports New EADV Data on Bimekizumab Treatment in HS</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CPHI Sustainability Summit Targets Practical Pharma Action</title>
		<link>https://www.worldpharmatoday.com/press-releases/cphi-sustainability-summit-targets-practical-pharma-action/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 12:26:27 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/cphi-sustainability-summit-targets-practical-pharma-action/</guid>

					<description><![CDATA[<p>CPHI Milan will host the inaugural CPHI Sustainability Summit at Fiera Milano on October 6–7, 2026, bringing together more than 300 companies and organisations from across the pharmaceutical supply chain to focus on practical sustainability action. Sponsored by SK Pharmteco, Alperia, AstraZeneca, Sharp, ERM, Pharma LCA Consortium, AllocNow and gesco, the two-day event will address [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/cphi-sustainability-summit-targets-practical-pharma-action/">CPHI Sustainability Summit Targets Practical Pharma Action</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Sterling Expands ADC Manufacturing Capacity and Capabilities</title>
		<link>https://www.worldpharmatoday.com/press-releases/sterling-expands-adc-manufacturing-capacity-and-capabilities/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 07:45:54 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/sterling-expands-adc-manufacturing-capacity-and-capabilities/</guid>

					<description><![CDATA[<p>Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has announced completion of an additional, large-scale GMP manufacturing suite at its dedicated bioconjugation facility in the UK, which will double capacity, as well as increasing the scale of manufacturing to 500L. The multi-million-pound investment has also seen the construction of a new analytical development laboratory [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/sterling-expands-adc-manufacturing-capacity-and-capabilities/">Sterling Expands ADC Manufacturing Capacity and Capabilities</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations</title>
		<link>https://www.worldpharmatoday.com/articles/eschbach-launches-new-digital-leader-standard-work-capability-for-pharma-process-operations/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 05 Oct 2026 11:20:47 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/eschbach-launches-new-digital-leader-standard-work-capability-for-pharma-process-operations/</guid>

					<description><![CDATA[<p>Seqonis Intelligent Operations by eschbach has a new dedicated capability called Leader Standard Work capability, which empowers pharmaceutical organizations to bring leadership routine planning, execution, documentation and evaluation into a single digital workflow. What does this mean for pharmaceutical manufacturers operating in highly regulated environments? Leadership activities can now be performed consistently as well as [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/eschbach-launches-new-digital-leader-standard-work-capability-for-pharma-process-operations/">eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>94th CMEF to Bring Global Medical Device Industry Together in Beijing</title>
		<link>https://www.worldpharmatoday.com/press-releases/94th-cmef-to-bring-global-medical-device-industry-together-in-beijing/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 07:40:34 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/94th-cmef-to-bring-global-medical-device-industry-together-in-beijing/</guid>

					<description><![CDATA[<p>BEIJING, Oct. 01, 2026 &#8211; The 94th China International Medical Equipment Fair (CMEF) will take place from October 21–24, 2026, bringing together participants from across the medical device value chain at the Capital International Exhibition &#38; Convention Center in Beijing. The event is expected to feature more than 3,000 exhibitors, 120,000+ professional visitors and 170,000 [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/94th-cmef-to-bring-global-medical-device-industry-together-in-beijing/">94th CMEF to Bring Global Medical Device Industry Together in Beijing</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Oncodesign Services and Nexus BioQuest Form Preclinical Partnership</title>
		<link>https://www.worldpharmatoday.com/press-releases/oncodesign-services-and-nexus-bioquest-form-preclinical-partnership/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 19 Sep 2026 08:36:39 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/oncodesign-services-and-nexus-bioquest-form-preclinical-partnership/</guid>

					<description><![CDATA[<p>Oncodesign Services and Nexus BioQuest have formed a partnership designed to connect complementary in vitro and in vivo capabilities, giving biotech companies a clearer route to specialist preclinical expertise as their development programs advance. Announced in Dijon, France &#8211; 16 September, 2026, the collaboration brings together Nexus BioQuest’s human-relevant in vitro capabilities and Oncodesign Services’ [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/oncodesign-services-and-nexus-bioquest-form-preclinical-partnership/">Oncodesign Services and Nexus BioQuest Form Preclinical Partnership</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>ACHEMA 2027 Strengthens India Process Industry Collaboration</title>
		<link>https://www.worldpharmatoday.com/press-releases/achema-2027-strengthens-india-process-industry-collaboration/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 23:00:42 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/achema-2027-strengthens-india-process-industry-collaboration/</guid>

					<description><![CDATA[<p>DECHEMA, EEPC INDIA and Messe Frankfurt India brought together more than 200 industry leaders, business stakeholders and professionals from India’s process, chemical, pharmaceutical and engineering sectors at a Networking Evening in New Delhi on 8 September 2026. Held at Hotel Shangri-La Eros, New Delhi, the event focused on industry interactions, knowledge exchange and business networking, [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/achema-2027-strengthens-india-process-industry-collaboration/">ACHEMA 2027 Strengthens India Process Industry Collaboration</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Onyx Scientific Boosts API Manufacturing Capacity in UK</title>
		<link>https://www.worldpharmatoday.com/press-releases/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 22:51:07 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/</guid>

					<description><![CDATA[<p>Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP suites, taking the total from six to ten, while increasing capacity for commercial API production and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/onyx-scientific-boosts-api-manufacturing-capacity-in-uk/">Onyx Scientific Boosts API Manufacturing Capacity in UK</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Neuland Expands Peptide Manufacturing Capacity in India</title>
		<link>https://www.worldpharmatoday.com/press-releases/neuland-expands-peptide-manufacturing-capacity-in-india/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 18 Sep 2026 22:31:56 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/neuland-expands-peptide-manufacturing-capacity-in-india/</guid>

					<description><![CDATA[<p>Neuland Laboratories is accelerating its peptide manufacturing expansion, with the first of four planned modules now operational at its commercial peptide manufacturing site in Hyderabad. The company said the newly commissioned module is designed to meet growing customer demand and support programmes ranging from small-scale to multikilogram quantities for complete peptide APIs, including complex and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/neuland-expands-peptide-manufacturing-capacity-in-india/">Neuland Expands Peptide Manufacturing Capacity in India</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Choosing the Right Supply Chain Strategy for Pharma Growth &#8211; Live Webinar</title>
		<link>https://www.worldpharmatoday.com/press-releases/choosing-the-right-supply-chain-strategy-for-pharma-growth-live-webinar/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 15 Sep 2026 07:27:44 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/choosing-the-right-supply-chain-strategy-for-pharma-growth-live-webinar/</guid>

					<description><![CDATA[<p>Pharmaceutical and life sciences businesses face stringent requirements around batch control, traceability and compliance, which cannot be an afterthought when scaling warehouse operations and supporting pharma growth. Ryan Gibbs and Grant Smith will examine these supply chain considerations in an upcoming webinar, “New Build, 3PL, AGV, AMR or AutoStore Robotics? Choosing the Right Supply Chain [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/choosing-the-right-supply-chain-strategy-for-pharma-growth-live-webinar/">Choosing the Right Supply Chain Strategy for Pharma Growth – Live Webinar</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
